Open Access

Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review)

  • Authors:
    • Zixin Chen
    • Limei Shao
    • Mingfeng Jiang
    • Xuejiao Ba
    • Bingjie Ma
    • Tao Zhou
  • View Affiliations

  • Published online on: October 4, 2022     https://doi.org/10.3892/etm.2022.11643
  • Article Number: 707
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Over past few decades, diabetes has become widespread on a global scale. Hemoglobin A1c (HbA1c) assessment is crucial for diabetes care, since it allows for the monitoring of an individual's level of glycemic control over the course of 2 to 3 months and risk assessment to determine any possible complications. Numerous methods, including cation‑exchange chromatography, electrophoresis, immunoassays and affinity chromatography, can be used to determine the HbA1c level. Each method has its limitations, however. The amount of HbA1c in patient samples is not only dependent on blood glucose levels, but is also strongly influenced by changes in red blood cell lifespan and globin chain structure. Consequently, hematological, clinical biochemistry and analytical methods all intertwine when interpreting HbA1c. There are numerous reports on the interactions of HbA1c with inherited and acquired diseases. Some of these impacts are inconsistent and difficult to explain. The present review article aimed to summarize and classify these effects and evaluate their clinical relevance. The findings discussed herein may serve as a reminder that clinical HbA1c values need to be analyzed with caution.
View Figures
View References

Related Articles

Journal Cover

December-2022
Volume 24 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Z, Shao L, Jiang M, Ba X, Ma B and Zhou T: Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Exp Ther Med 24: 707, 2022
APA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., & Zhou, T. (2022). Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Experimental and Therapeutic Medicine, 24, 707. https://doi.org/10.3892/etm.2022.11643
MLA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review)". Experimental and Therapeutic Medicine 24.6 (2022): 707.
Chicago
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review)". Experimental and Therapeutic Medicine 24, no. 6 (2022): 707. https://doi.org/10.3892/etm.2022.11643